This is a delivery order issued under a multi-year Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Multaq (400 mg tablets), with a ceiling value of $3,790.41 and a period of performance through December 31, 2024. This IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside requirements, indicating open competition. In addition to the DLA contract, AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs.
Generated 3/31/25, 9:34 AM